Product Information
ALAHIST PE 2-7.5 MG TABLET is a generic product labeled by Poly Pharmaceuticals, Inc., priced at $0.6539 per EA under NDC 50991078890. Its NADAC has been published 184 times since Dec 21, 2022.
Strength
2; 7.5 mg/1; mg/1
Manufacturer
Poly Pharmaceuticals, Inc.NDC
50991078890
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
DEXBROMPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDEApproval Type
OTC MONOGRAPH DRUG
FDA Application
M012On Market Since
8/24/2020
Pharmacological Classes
Price Statistics
The NADAC for ALAHIST PE 2-7.5 MG TABLET has been published 184 times since Dec 21, 2022, and over the history we have for it it has risen 2.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6539 per EA |
|---|---|
| All-time high | $0.6661 (Apr 15, 2026) |
| All-time low | $0.6206 (Apr 17, 2024) |
| 52-week high | $0.6661 |
| 52-week low | $0.6539 |
| Median price | $0.6595 |
| Average price | $0.6508 |
| Largest weekly change | +7.2% (May 22, 2024) |
| Weeks tracked | 184 |
| Tracking since | Dec 21, 2022 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Dexbrompheniramine Maleate, Phenylephrine Hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of ALAHIST PE 2-7.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ALAHIST PE 2-7.5 MG TABLET, manufactured by Poly Pharmaceuticals, Inc., is $0.6539 per EA (NDC 50991078890), effective Jun 24, 2026.
How has the price of ALAHIST PE 2-7.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for ALAHIST PE 2-7.5 MG TABLET has risen 2.1%. It has been tracked across 184 weekly CMS publications since Dec 21, 2022.
What are the highest and lowest recorded NADAC prices for ALAHIST PE 2-7.5 MG TABLET?
Since Dec 21, 2022, the NADAC for ALAHIST PE 2-7.5 MG TABLET has ranged from a low of $0.6206 (Apr 17, 2024) to a high of $0.6661 (Apr 15, 2026), with a median of $0.6595 per EA.
Are there cheaper alternatives to ALAHIST PE 2-7.5 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of ALAHIST PE 2-7.5 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures ALAHIST PE 2-7.5 MG TABLET?
ALAHIST PE 2-7.5 MG TABLET (NDC 50991078890) is labeled by Poly Pharmaceuticals, Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification